Tesamorelin

Tesamorelin stands out from other GH-releasing agents by combining potent receptor engagement with a half-life optimized for research applications. Its 44-residue design enhances stability just enough to generate clean GH peaks—yet clears rapidly to avoid receptor desensitization or off-target hormone elevations such as cortisol or prolactin. This unique pharmacokinetic profile allows researchers to dissect GH-IGF-1-lipolysis pathways with unprecedented temporal resolution. From high-throughput cell assays to longitudinal rodent models, Tesamorelin’s proven reliability and minimal hormonal “noise” set a new standard for GH-axis and metabolic-health studies. GH pulses from Tesamorelin lead to consistent IGF-1 upregulation in hepatocyte and myoblast models, creating a robust platform to study anabolic signaling, protein synthesis, and cell-growth dynamics.

Regulatory & Use: Tesamorelin is offered strictly for in-vitro laboratory research. Not for human or animal consumption.